Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

May Day Special: Promoting the Spirit of Craftsmanship, Labor Writes the Era—Lin Qixin, Director of Maixin Automation, Among Fuzhou’s Top Ten Craftsmen of 2019

Editor's Note:Promoting the spirit of craftsmanship, labor writes the era. On April 29, to commendthe outstanding frontline workers who...
Continue reading
06 2 月
Immunohistochemistry Technology Exchange
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Dual Antigen Retrieval Method for Paraffin-Embedded Tissue Sections (Trypsin + Citric Acid)

1. Instruments and equipment: Stainless steel pressure cooker (Maixin product number: HPC-1001), high-temperature resistant plastic sta...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Immunohistochemical Phenotype of Renal Cell Carcinoma

Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Master’s Diary: Insights on Technical Quality Control

Introduction:For technical 'workers', quality control is a topic all too familiar. Whether in large or small meetings, or in long or sh...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Ki-67: Prospects, Potential, and Challenges in Breast Cancer (Part 1)

Introduction:Ki-67 is a nuclear protein accidentally discovered during the screening of monoclonal antibodies in the early 1980s. Altho...
Continue reading
06 2 月
Immunohistochemistry and Pathology
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Basic Immunohistochemical Markers for Lymphoid Tumors

Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Maxin with You, Riding the Wind and Waves, Better Together 2023 | Maxin Biotech Outstanding Employee Team Building Event

Introduction:"With you, Maxin thrives and flourishes." There is such a group of people who, at work, stick to their posts and contribut...
Continue reading
06 2 月
Immunohistochemistry Technology Exchange
Posted by author-avatar fzmaixinswy@163.com
9 2 月, 2026
0

Instructions for Using Citric Acid Tissue Antigen Retrieval Solution (100x)

1. Product Number: MVS-0100/01012. Product Form: Liquid, concentrated type (100×).3. Usage Method: Dilute according to the required amo...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Week 35 of “Mai Mai” Pathology Reading Notes | Immunohistochemical Markers for Diagnosing Vascular Tumors and Perivascular Tumors

Introduction:Vascular tumors and perivascular tumors generally have clear morphological features, but depending on the degree of differ...
Continue reading
06 2 月
Maxxin Dynamics
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Maxxin Biotech and Partners Engage in Sports Exchange

To enrich employees' leisure life, improve their physical fitness, and enhance the company's cohesion, Maixin Company organized sports ...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar